seed
Stage
About
Thestra develops diagnostic solutions using proprietary AI-based technology to assess the aggressiveness of head and neck squamous cell carcinoma, enabling clinicians to tailor personalized cancer treatments.
Explore Thestra's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.